Insider · CIK 0001698324
Andrea Anigati Kramer
cooofficerowner
Files at HLNE (Hamilton Lane INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | HLNE Hamilton Lane INC | AGrant or award Class A Common Stock | +27 | $67.01 | $1,809 | 87,377 | 24 d ago |
| Sep 16, 2026 | HLNE Hamilton Lane INC | FTax withholding Class A Common Stock | -736 | $93.03 | $68k | 86,641 | 24 d ago |
| Sep 16, 2026 | HLNE Hamilton Lane INC | AGrant or award Performance Stockderivative | +22,252 | $0.00 | $0 | 22,252 | 24 d ago |
| Mar 31, 2025 | HLNE Hamilton Lane INC | AGrant or award Class A Common Stock | +42 | $126.37 | $5,308 | 64,080 | Sep 18, 2025 |
| Sep 16, 2025 | HLNE Hamilton Lane INC | FTax withholding Class A Common Stock | -736 | $146.53 | $108k | 63,344 | Sep 18, 2025 |
| Sep 16, 2025 | HLNE Hamilton Lane INC | AGrant or award Performance Stockderivative | +2,033 | $0.00 | $0 | 2,033 | Sep 18, 2025 |
| Sep 30, 2024 | HLNE Hamilton Lane INC | AGrant or award Class A Common Stock | +26 | $143.13 | $3,721 | 62,111 | Mar 18, 2025 |
| Dec 31, 2024 | HLNE Hamilton Lane INC | AGrant or award Class A Common Stock | +42 | $125.84 | $5,285 | 62,153 | Mar 18, 2025 |
| Mar 14, 2025 | HLNE Hamilton Lane INC | AGrant or award Class A Common Stock | +3,001 | $0.00 | $0 | 65,154 | Mar 18, 2025 |
| Mar 14, 2025 | HLNE Hamilton Lane INC | FTax withholding Class A Common Stock | -1,116 | $139.01 | $155k | 64,038 | Mar 18, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.